Hernia mesh claims: who can file and what to do

What is happening in the case right now, and what does that mean for someone new?

An Ohio court set up a Bard mesh fund in December 2024 and issued case-procedure orders in 2026. Those records concern Bard and Davol products. If you are new, ask a lawyer to check the current route for your exact mesh. [10] [12]

The March 3, 2026 order is signed by Judge Edmund A. Sargus, Jr. It governs responses to changed complaints in the Ohio federal group numbered 2846. It does not decide that a product caused every injury or announce a new offer to all patients. The defendants retain defenses to new or different claims. [12]

A February 19, 2026 order deals with cases that were dismissed and not filed again in that group. That rule has a different purpose from the fund order. Neither record establishes the stage of a case about another maker’s mesh. Bring the actual implant record so the lawyer can distinguish court procedure, private terms and your own filing route. [11] [10] [12]

What does it cost to get help?

Before hiring a firm for a mesh claim, request the fee and expense terms in writing. Ask how its share of any money recovered would work. Find out what you could owe after a loss as well as after a recovery. [3] [5]

Ask who pays for the implant file, court fees and any outside expert work while the claim is reviewed or pursued. The ABA consumer guide distinguishes a lawyer’s share from costs that may remain payable without a win. Its model rule describes written terms for fees based on the result. These sources are not proof of the receiving firm’s price or your state’s exact rule. [3] [5]

For your own surgery and care records, ask the provider about copying and mailing charges before ordering. HHS permits reasonable copying costs for covered providers, but not a search fee for your own file. Ask the lawyer which hospitals and dates it needs. A focused request may avoid paying for a larger file than the review needs. [1]

What should I do today?

Ask your treating surgeon about pain, a possible infection or a hernia that has returned. Ask what evaluation and care are needed for your situation. Keep the medical decision separate from checking a legal claim. [6] [7]

Request the implant details from the hospital or doctor’s office. FDA specifically suggests keeping the maker, brand, material and device identifier after surgery. Save the report from any further procedure too. If a record is missing, tell the lawyer what you know and ask which record it needs first. Do not guess the product from a company name in an advertisement. [7]

A recall does not always mean an implanted device must be removed. FDA explains that doctors should consider the risk of removal against leaving a device in place. Ask your surgeon whether any notice applies to your actual implant and what it means for care. This page does not tell you to have mesh taken out to support a claim. [9]

If you help a relative, first ask for their permission and find out who can request records. HHS describes access for the patient or a proper personal representative, subject to limits. Ask the hospital how it handles that authority. Keep sensitive records out of public messages while you work out where the review should go. [1]

What is the evidence that the product causes this?

FDA identifies risks after hernia repair both with and without mesh, plus risks of mesh movement or shrinkage. That is not a finding that every product is defective. Ask your surgeon what caused the problem in your records and what is still uncertain. [6]

An original study randomly assigned 253 adults to two types of mesh during a specific abdominal hernia repair. Over two years, the synthetic mesh group had fewer returning hernias than the animal-tissue mesh group. The study found no clear difference in wound problems that required a procedure. It compares two treatments rather than deciding the cause of your injury. [13]

The study covered five specialist centers, two materials and a particular placement method. Its results cannot describe every mesh model, groin repair or long-term outcome. The authors warn that a trial of this size may miss rare severe problems. Some authors disclosed industry relationships. Read the study’s limits alongside the finding, rather than treating a positive result as proof of all-product safety. [13]

FDA also reviews reports of problems, but says reports alone rarely confirm cause and effect. Reports can be incomplete or unverified. They are useful safety signals, not a way to calculate your risk or prove a defect from timing alone. A doctor’s assessment, the implant record and the applicable legal evidence still matter for an individual claim. [8]

Sources

The FDA pages explain care, records and the limits of safety reports. The original trial compares two treatments in a defined repair. The Ohio orders concern Bard and Davol court work; their dates do not describe every mesh maker. Citing the authors or judge does not mean they reviewed this guide.

Mesh Migration and Organ Adhesion

Mesh migration is the displacement of a hernia mesh implant from its original surgical position, occurring as the polypropylene material shrinks (contracts) over time and pulls away from anchoring sutures or fixation tacks. Migrated mesh can travel into adjacent anatomical compartments and adhere to the bowel, bladder, blood vessels, or the abdominal wall fascia, forming dense fibrous adhesions. Adhesions are scar tissue bands that bind structures that are normally free to move — when mesh adheres to the bowel, it can cause chronic pain, intermittent obstruction, and ultimately complete bowel obstruction requiring emergency surgery. Polypropylene mesh is known to cause a chronic foreign body inflammatory response that promotes adhesion formation, a risk that manufacturers were aware of and attempted to address with barrier coatings — coatings that have themselves been the subject of litigation when found to degrade unpredictably.

• Chronic or intermittent abdominal pain, often worse with activity
• Palpable lump or firmness at the mesh site that was not present previously
• Nausea, bloating, and alternating constipation and diarrhea
• Bowel obstruction — inability to pass gas or stool, vomiting
• Urinary frequency or difficulty urinating if mesh migrates toward bladder
• Inadequate mesh pore size reducing tissue ingrowth and secure fixation
• Lightweight polypropylene mesh with higher shrinkage rates
• Composite mesh with degradable coatings that fail to prevent adhesion
• Laparoscopic intraperitoneal mesh placement (mesh contacts bowel directly)
• Prior abdominal surgeries creating adhesion-prone environment
• CT scan and MRI to confirm migration and adhesion extent
• Surgical lysis of adhesions (adhesiolysis) to free bound structures
• Partial or complete mesh explantation (removal) — high complexity surgery
• Bowel resection if bowel segment is non-viable due to adhesion/strangulation
• Reconstruction of hernia defect following mesh removal with biological mesh or primary repair

Chronic Pain Syndrome and Nerve Entrapment

Chronic pain following inguinal hernia mesh repair — termed inguinodynia — is one of the most common and debilitating complications of polypropylene mesh implantation. The inguinal region (groin) is served by three major sensory nerves: the ilioinguinal nerve, the iliohypogastric nerve, and the genitofemoral nerve. Mesh fixation devices (tacks, staples, or sutures) can directly entrap these nerves, causing sharp, burning, or shooting pain in the groin, inner thigh, and genital area. Additionally, mesh shrinkage and the surrounding inflammatory response can compress and distort nerve anatomy over time. Chronic pain can also result from mesh impingement on the spermatic cord structures in male patients, causing testicular pain and sexual dysfunction. Neuropathic pain from mesh nerve entrapment is notoriously difficult to treat and often persists even after mesh removal if nerve damage has occurred.

• Persistent burning, shooting, or sharp groin pain lasting more than 3 months after surgery
• Hypersensitivity (allodynia) — pain triggered by light touch or clothing on the groin area
• Testicular pain, scrotal swelling, or sexual dysfunction in male patients
• Pain radiating into the inner thigh, lower abdomen, or perineum
• Failure to obtain relief from opioids, neuropathic medications, or nerve blocks
• Inguinal hernia repair (proximity of ilioinguinal and genitofemoral nerves to mesh)
• Mesh fixation with metallic tacks or permanent sutures near nerve pathways
• Heavyweight mesh with high friction against nerve fibers during shrinkage
• Bilateral hernia repair (doubles nerve exposure risk)
• Prior inguinal surgeries creating scarring that alters nerve anatomy
• Neuropathic pain medications (gabapentin, pregabalin, duloxetine)
• Selective nerve blocks (ilioinguinal, genitofemoral, or pelvic floor blocks)
• Neurectomy — surgical division of entrapped nerves as pain management measure
• Mesh removal (meshectomy) combined with neurectomy for refractory cases
• Physical therapy and pelvic floor rehabilitation
• Pain psychology and multidisciplinary chronic pain management programs

Corporate Accountability in the Hernia Mesh Litigation

The hernia mesh litigation involves the largest medical device companies in the world — Davol/Bard (a subsidiary of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Covidien (now part of Medtronic), and Atrium Medical. Internal documents obtained through discovery reveal that multiple manufacturers were aware of elevated failure rates, recurring complications, and structural defects years before patients or surgeons received adequate warnings.

Concealment of Safety Data and Delayed Disclosure

Discovery in the Bard and Ethicon MDLs has produced internal documents showing both companies received evidence of elevated failure rates years before disclosing safety information to surgeons or regulatory authorities. Plaintiffs have raised this concealment theme in bellwether trials.

• Ethicon received Danish and German registry data showing elevated Physiomesh complication rates in 2014 and 2015 but did not disclose this data or modify promotional materials until the 2016 withdrawal
• Bard/Davol internal documents show the company received early reports of Composix Kugel ring fractures before the 2012 recall but did not promptly notify the FDA or surgeons
• Neither Bard nor Ethicon issued direct physician letters or patient notifications after withdrawing products — relying instead on quiet market withdrawal to minimize litigation exposure
• Plaintiff expert witnesses in MDL bellwether trials have introduced internal emails showing sales representatives were instructed to continue promoting withdrawn products until existing inventory was depleted

Moody's

Becton Dickinson outlook revised to negative (2023)

Hernia mesh and other product liability litigation cited as material financial risk factor

S&P Global

J&J Consumer segment spin-off monitoring note (2023)

J&J's Kenvue spin-off restructuring evaluated in context of ongoing Ethicon and talc litigation exposure

Two of the world's largest medical device companies — divisions of Becton Dickinson and Johnson and Johnson — received evidence of hernia mesh failures years before patients or surgeons were warned. The combination of 510(k) clearance without clinical trials, internal concealment of registry data, and quiet market withdrawals without patient notification defines the corporate conduct that the federal hernia mesh lawsuits seek to hold accountable; Bard/Davol MDL 2846 alone has had 25,217 actions (23,324 pending as of Oct. 1, 2026, JPML).

Hernia Mesh Lawsuit Filing Deadlines

The statute of limitations for hernia mesh claims is typically 2 to 3 years, but the clock does not necessarily start on the date of your original surgery. In most states, the discovery rule applies — the limitations period begins when you knew or reasonably should have known that your injury was caused by a defective mesh product. This is critical because mesh complications often surface months or years after implantation.

The Discovery Rule and Hernia Mesh Claims

Unlike a car accident where the injury is obvious on day one, hernia mesh defects often cause delayed complications. A patient implanted with Davol Composix E/X mesh in 2018 may not develop a mesh infection requiring revision surgery until 2022 or 2023. Under the discovery rule, the statute of limitations in most states begins running when the patient (1) discovered the injury (e.g., was told by a surgeon the complication was caused by the mesh) or (2) reasonably should have discovered the connection between their symptoms and the mesh. Courts have consistently applied the discovery rule to medical device claims, meaning patients implanted years ago may still have timely claims if their complications are recent. However, each state applies the discovery rule differently and some states impose an absolute outside limit (a statute of repose) of 10 to 12 years from implantation regardless of discovery. Claims against Davol/C.R. Bard in MDL 2846 are governed by Ohio choice-of-law principles in many cases, but individual state law applies in others. An attorney must evaluate the specific state law applicable to each claimant.

A patient in Texas received Davol 3DMax mesh for inguinal hernia repair in January 2020. In March 2024 she was diagnosed with mesh migration and underwent revision surgery. She contacts an attorney in August 2025.

Texas has a 2-year statute of limitations for product liability claims (Tex. Civ. Prac. & Rem. Code § 16.003), measured from the date of discovery. Discovery occurred in March 2024 when the mesh migration was diagnosed. Measured from discovery, her deadline would generally be March 2026. Tolling rules and other exceptions can change that, so whether the time has passed depends on her facts. A lawyer can tell her.

A patient in Ohio received Bard Marlex mesh in 2015 and developed chronic groin pain within 6 months but did not pursue legal action until 2025.

Ohio has a 2-year statute of limitations for product liability (ORC § 2305.10). The question is when discovery occurred. If the patient's treating physician attributed the chronic pain to the mesh as early as 2016, the limitations period may have begun then — making a 2025 filing untimely. Ohio also has a statute of repose of 10 years from the date of first sale of the product to the plaintiff. An attorney must carefully evaluate the discovery date and Ohio's repose provisions. This case illustrates why the discovery date matters. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you.

Do not assume your claim is too old because your surgery was years ago. The discovery rule extends the deadline in most states. But once you identify a mesh-related complication or receive a diagnosis linking your symptoms to the implant, the limitations clock begins. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you.